Barclays Maintains Equal-Weight on CME Group, Raises Price Target to $321
Barclays analyst Benjamin Budish maintains CME Group (NASDAQ:CME) with a Equal-Weight and raises the price target from $281 to $321.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga